Dr Harriet Teare is the Deputy Director of Partnerships at the UK Medicines and Healthcare products Regulatory Agency (MHRA), in the policies and partnerships team. She recently joined the MHRA, having previously worked in academic research, as the Programme Director for a UK-wide collaboration called UK SPINE (led by University of Oxford) which considered how to develop treatments to tackle multimorbidity and improve healthspan (healthy life years). Dr Teare supports evidence-based policy development, in collaboration with health stakeholders across the UK and international landscape to help ensure patients have timely access to safe and effective treatment. She originally trained as a chemist at the University of Oxford, before embarking on a career at the interface between research and policy, first at Cancer Research UK, then as an empirical researcher, then Deputy Director, at the Centre for Health, Law and Emerging Technologies (HeLEX) (University of Oxford), and subsequently as a Research Leader at RAND Europe (an independent not-for-profit research organisation). Through these initiatives she has endeavoured to ensure that research findings are translated to make better health more accessible, while no one gets left behind.